Recent Quotes (30 days)

You have no recent quotes
chg | %

Kopran Limited (Parent)  

(Public, BOM:524280)   Watch this stock  
Find more results for 524280
-1.75 (-2.67%)
Dec 15 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 63.10 - 67.10
52 week 48.90 - 102.50
Open 66.00
Vol. 58,487.00
Mkt cap 2.73B
P/E 11.64
Div/yield     -
EPS 5.49
Shares 43.25M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 2.03% 8.01%
Operating margin 2.77% 9.05%
EBITD margin - 11.74%
Return on average assets - 8.82%
Return on average equity - 22.04%
Employees 347 -
CDP Score - -


Parijat House 1076, Dr. E. Moses Road, Worli 9917
MUMBAI, 400018
+91-22-43661111 (Phone)
+91-22-24950363 (Fax)

Website links


Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare. It offers its products in therapeutic categories, such as anthelmintic, anti-allergic, antibiotic, cardiovascular, diabetic, gastroenterology, pain and antipyretic, and pain management, among others. The Company's bulk drugs include Atenolol, Amlodipine Besylate, Metoprolol Succinate, Metoprolol Tartrate, Ceftriaxone Sodium Sterile, Doripenem, Tebipenem, Roxithromycin, Rivaroxaban, Zolmitriptan, Azithromycin, Pregabalin, Lymecycline and Nitroxoline. In addition, it offers oral care, lifestyle, beauty and personalized hygiene products. Its manufacturing facility is located at Khopoli, Raigad District, Maharashtra. The Company's subsidiaries include Kopran Research Laboratories Limited, Kopran (H.K) Limited and Kopran Lifesciences Limited.

Officers and directors

Surendra Somani Executive Vice Chairman of the Board
Age: 57
Ajit Jain Chief Operating Officer
Age: 50
Sunil Sodhani Compliance Officer, Company Secretary
Susheel G. Somani Director
Sunita Banerji Additional Independent Director
V. K. Bhandari Independent Director
Siddhan Subramanian Additional Independent Director
A. K. Mehta Non-Executive Independent Director